Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Naughton

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Mbio|October 9, 2014
Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formationMartin A Bewley, Michael Naughton, Julie Preston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Cesar Sanchez, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2014
Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancerVenkataswarup Tiriveedhi, Natalia Tucker, John Herndon, et al.
Breast Cancer Research and Treatment|November 1, 2015
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivorsWendy Demark-Wahnefried, Graham A Colditz, Cheryl L Rock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2013
A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancerAdam A Garsa, Daniel J Ferraro, Todd A DeWees, et al.
Contemporary Clinical Trials|December 26, 2012
Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) TrialCheryl L Rock, Tim E Byers, Graham A Colditz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2016
Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivorsRebecca L Sedjo, Shirley W Flatt, Tim Byers, et al.
Cancer Medicine|December 22, 2015
Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancerShariq S Khwaja, Jennifer Ivanovich, Todd A DeWees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer SurvivorsCheryl L Rock, Shirley W Flatt, Tim E Byers, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Mbio|October 9, 2014
Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formationMartin A Bewley, Michael Naughton, Julie Preston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Cesar Sanchez, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2014
Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancerVenkataswarup Tiriveedhi, Natalia Tucker, John Herndon, et al.
Breast Cancer Research and Treatment|November 1, 2015
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivorsWendy Demark-Wahnefried, Graham A Colditz, Cheryl L Rock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2013
A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancerAdam A Garsa, Daniel J Ferraro, Todd A DeWees, et al.
Contemporary Clinical Trials|December 26, 2012
Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) TrialCheryl L Rock, Tim E Byers, Graham A Colditz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2016
Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivorsRebecca L Sedjo, Shirley W Flatt, Tim Byers, et al.
Cancer Medicine|December 22, 2015
Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancerShariq S Khwaja, Jennifer Ivanovich, Todd A DeWees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer SurvivorsCheryl L Rock, Shirley W Flatt, Tim E Byers, et al.
Pageof 5